Published date: Mar 08 2023

Journal Title: KnE Medicine

Issue title: 2nd International Conference on Medical Health Science (2nd ICMEDH)

Pages: 48–60

DOI: 10.18502/kme.v3i2.13036

Nur Lailatul Masrurohnmasruroh99@gmail.comNursing Department, Health Sciences Faculty, University of Muhammadiyah Malang

Imelda Devi OktavianaNursing Department, Health Sciences Faculty, University of Muhammadiyah Malang

Chairul Huda Al HusnaNursing Department, Health Sciences Faculty, University of Muhammadiyah Malang

Nur MelizzaNursing Department, Health Sciences Faculty, University of Muhammadiyah Malang

Anggraini Dwi KurniaNursing Department, Health Sciences Faculty, University of Muhammadiyah Malang

Vaccination is used to stop the transmission of COVID-19. However, it can stimulate Adverse Event Following Immunization (AEFI) symptoms, ranging from mild to severe. This study aims to identify the signs and symptoms of AEFI of the COVID-19 vaccine in the Malang City Community. The research design used is a descriptive survey. The sampling technique used was accidental sampling (n=275). The sample criteria were able and willing to fill out the questionnaire by accessing the google form from the researcher. Data were analysed using the Descriptive Statistical Analysis Test. The results of the study indicated that the number of respondents who experienced AEFI after receiving dose 1 vaccine was 97 people (35.2%), with symptoms including fever in 96 people (34.9%), swelling or redness at the injection site in 13 people (4.7%), pain in the injection site in 44 people (16.0%) and 1 person (0.4%) experienced other symptoms that required medical attention. After the second dose of the vaccine, 63 people (22.9%) had a fever, 11 people (4.0%) experienced swelling or redness at the injection site, 18 people (6.5%) experienced pain at the injection site, and 3 people (1.0 %) had other symptoms that required treatment. Signs and symptoms of AEFI of the COVID-19 vaccine most experienced by respondents after vaccine doses 1 and 2 were fever, pain at the injection site, and swelling or redness at the injection site, and there were no severe signs of AEFI were found in this study.

Keywords: AEFI, Covid-19 vaccine, signs, symptoms

[1] Budiman SS. Saleh M, Bahtiar, Muchsin A, Fikri, et al. 19 Covid Pandemic in 19 Perspectives. South Sulawesi: IAIN Parepare Nusantara Press; 2020.

[2] Zendrato W. Movement to prevent rather than cure the Covid-19 pandemic. J Educ Dev. 2020;8(2):242–8.

[3] Tantona MD. Clinical Characteristics of 2019 Coronavirus Disease. J Researcher- Nurse Prof. 2020;1(November):89–94.

[4] WHO. Coronavirus Disease (COVID-19). Situation Report-114. 2020.

[5] Indonesian Ministry of Health. Information on Emerging Infections of the Indonesian Ministry of Health; 2020.

[6] Goddess D. How to prevent the spread of covid-19. 2020.

[7] Rachmawati SD (Press TU, editor). Immunization practical guidelines in children. Poor; 2019.

[8] Aidah SN. Mandatory Reading! Corona Vaccine. Indonesian KBM Publishing Team; 2021.

[9] CDC. CDC’s COVID-19 Vaccine Rollout Recommendations. 2021.

[10] Islam MS, Siddique AB, Aktera R, Tasnima R, Sujana MSH, Ward PR, et al. Knowledge, attitudes and perceptions towards COVID-19 vaccinations: a cross-sectional community survey in Bangladesh. BMS Public Health. 2021. https://doi.org/10.1186/s12889-021-11880-9.

[11] Sembiring J. TEACHING BOOK OF NEONATES, INFANTS, TOddlers, PRE-SCHOOL CHILDREN. Glimpse. 2019.

[12] El-Elimat T, AbuAlSamen MM, Almomani BA, Al-Sawalha NA, Alali FQ. Acceptance and attitudes toward COVID-19 vaccines: A cross-sectional study from Jordan. PLOS One. 2021;16:1–15.

[13] Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021 Feb;27(2):225–8.

[14] Ciarambino T, Barbagelata E, Corbi G, Ambrosino I, Politi C, Lavalle F, et al. Gender differences in vaccine therapy: where are we in COVID-19 pandemic? Monaldi Arch Chest Dis. 2021Apr;91(4). https://doi.org/10.4081/monaldi.2021.1669.

[15] Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg Heal - Eur; 2021. p. 1.

[16] Noer Febriyanti et al. The Relationship between Knowledge Levels and Willingness to Vaccinate Covid-19 on Residents of Dukuh Menanggal Village, Surabaya City. Semin Nas Has Ris and Servants. 2021;3:1–7.

[17] Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, et al. Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia. Front Public Health. 2020 Jul;8:381.

[18] Indriyanti D. Health Center Officers’ Perceptions of the Implementation of Covid-19 Vaccination in the New Normal Era Perceptions of Public Health Center Officers on the Implementation of Covid-19 Vaccination in the New Normal Era. J Inspiration. 2021;12(1):29.

[19] Fitriani NI. Literature review covid-19: virology, pathogenesis, and clinical manifestation. MalaysianPalm Oil Counc. 2020;21(1):1–9.

[20] Arumsari W, Desty RT, Eko W, Kusumo G. Indonesian Journal of Community Health Overview of COVID-19 Vaccine Acceptance in Semarang City Info Articles. Indonesia J Heal Community 2. 2021;2(1):35- 45-undefined.

[21] Rahayu CD, Mulyani S. Health Scientific Journal 2020 Health Scientific Journal 2020. J Health Science. 2020;19(May):33–42.

[22] Koesnoe S. Technical Implementation of the Covid Vaccine and Anticipation AEFI. Association of Dr Specs Internal Medicine in Indonesia; 2021. pp. 1–65.

[23] Ministry of Health. COVID-19 Vaccination. Indonesian Ministry of Health; 2021. pp. 2–5.